CIK 0001953926
- Emerging growth company
Zenas BioPharma, Inc.
Sign in to watch- Ticker
- ZBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-271-2954
- Business address
- 852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
- Former names
- Zenas BioPharma (Cayman) Ltd
- 4 Open-market buy Director bought 19,860 shares at an average $25.16 ($499,746)
- 4 Open-market buy Chief Executive Officer bought 57,000 shares at $17.96 ($1,023,720)
- 4 Open-market buy Chief Executive Officer bought 100,000 shares at an average $16.39 ($1,639,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 63,158 shares at $19.00 ($1,200,002)
- 4 Open-market buy 10% owner bought 126,315 shares at $19.00 ($2,399,985)
- 4 Open-market buy Director bought 117,255 shares at an average $19.19 ($2,250,027)
- 4 Open-market buy MOULDER LEON O JR bought 36,928 shares at $20.85 ($769,949)
- 4 Open-market buy Director bought 316,219 shares at $19.00 ($6,008,161)
- 4 Open-market buy Director bought 321,983 shares at an average $18.63 ($6,000,031)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 5 · 84 filings